Search
Feed aggregator
Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff
Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff 7/12/2024
FDA Decision Tracker: Novo’s Once-Weekly Insulin Icodec Rejected
FDA Decision Tracker: Novo’s Once-Weekly Insulin Icodec Rejected 7/12/2024
EMA Finds No Link Between GLP-1 Drugs and Suicidal Thoughts, Self-Harm
EMA Finds No Link Between GLP-1 Drugs and Suicidal Thoughts, Self-Harm 4/12/2024
EC Approves Illumina’s Plan to Divest Cancer Diagnostics Maker Grail
EC Approves Illumina’s Plan to Divest Cancer Diagnostics Maker Grail 4/12/2024
AACR, Cancer Treatment and the Promise of Antibody-Drug Conjugates
AACR, Cancer Treatment and the Promise of Antibody-Drug Conjugates 4/12/2024
Enlivex’s Stock Plummets 50% on Phase II Sepsis Results for Cell Therapy
Enlivex’s Stock Plummets 50% on Phase II Sepsis Results for Cell Therapy 4/12/2024
Lilly Suffers Legal Loss in Tirzepatide Case Against Compounding Pharmacy
Lilly Suffers Legal Loss in Tirzepatide Case Against Compounding Pharmacy 4/12/2024
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma 4/12/2024
Fujifilm Pumps $1.2B into CDMO Capacity in North Carolina, Eyes 680 New Jobs by 2031
Fujifilm Pumps $1.2B into CDMO Capacity in North Carolina, Eyes 680 New Jobs by 2031 4/12/2024
Vaccines, Next-Gen Approaches Target the Toughest Cancers: AACR
Vaccines, Next-Gen Approaches Target the Toughest Cancers: AACR 4/12/2024
CryoEM: Evolution and Best Practices
CryoEM: Evolution and Best Practices 4/12/2024
Pfizer Moves Forward With Obesity Pill, Plans Dose Optimization Studies This Year
Pfizer Moves Forward With Obesity Pill, Plans Dose Optimization Studies This Year 7/11/2024
Ipsen Inks Potential $1B First-in-Class ADC Deal With Foreseen
Ipsen Inks Potential $1B First-in-Class ADC Deal With Foreseen 7/11/2024
Kazia Offers Secondary OS Data to Build FDA Case for Glioblastoma Drug
Kazia Offers Secondary OS Data to Build FDA Case for Glioblastoma Drug 7/11/2024
FDA Rejects Novo’s Once-Weekly Insulin Injection, Cites Manufacturing Process
FDA Rejects Novo’s Once-Weekly Insulin Injection, Cites Manufacturing Process 7/11/2024
FTC to Sue ‘Big Three’ PBMs for Setting Insulin, Other Drug Prices: WSJ
FTC to Sue ‘Big Three’ PBMs for Setting Insulin, Other Drug Prices: WSJ 7/11/2024
FTC Ban That Would Make Switching Jobs Easier Hits Roadblock
FTC Ban That Would Make Switching Jobs Easier Hits Roadblock 7/11/2024
Syntis Bio Launches in Effort to Challenge GLP-1s in Lucrative Weight Loss Ma...
Syntis Bio Launches in Effort to Challenge GLP-1s in Lucrative Weight Loss Ma... 6/11/2024
Ipsen, Genfit’s Elafibranor Wins FDA Approval for Primary Biliary Cholangitis
Ipsen, Genfit’s Elafibranor Wins FDA Approval for Primary Biliary Cholangitis 6/11/2024
Sage’s Dalzanemdor Shows Effect in Huntington’s Study, Analysts Say Results ‘Underwhelming’
Sage’s Dalzanemdor Shows Effect in Huntington’s Study, Analysts Say Results ‘Underwhelming’ 6/11/2024
World Pharma News
- Bristol Myers Squibb announces collaboration with Microsoft to advance AI-driven early detection of lung cancer
- How psoriasis affects joints
- New EPIVINF study highlights a promising model for Long COVID research
- Plant discovery could lead to new ways of producing medicines
- A protein found in the GI tract can neutralize many bacteria